Squamous cell carcinoma of anal skin
ICD-10 C44.520 is a billable code used to indicate a diagnosis of squamous cell carcinoma of anal skin.
Squamous cell carcinoma (SCC) of the anal skin is a malignant neoplasm arising from the squamous epithelial cells in the anal region. This type of skin cancer is often associated with chronic sun exposure, immunosuppression, and HPV infection. Clinically, patients may present with symptoms such as anal pain, bleeding, or a visible lesion. Diagnosis typically involves a biopsy to confirm the presence of malignant cells. Treatment options may include surgical excision, radiation therapy, or chemotherapy, depending on the tumor's size, location, and stage. Surgical margins are critical in ensuring complete removal of the cancerous tissue, and reconstruction may be necessary to restore anal function and appearance post-surgery. The prognosis for SCC of the anal skin varies based on early detection and treatment, with a higher risk of metastasis if not treated promptly.
Detailed pathology reports, treatment plans, and follow-up notes.
Patients presenting with anal lesions, requiring biopsy and treatment planning.
Ensure accurate staging and documentation of any metastasis.
Operative reports detailing excision and reconstruction procedures.
Surgical intervention for SCC, including margin assessment and reconstruction.
Document the extent of excision and any complications during surgery.
Used when excising a large SCC of the anal skin.
Operative report detailing the excised lesion and margins.
Oncologists and surgeons must ensure accurate measurement of the lesion.
Common treatments include surgical excision, radiation therapy, and in some cases, chemotherapy. The choice of treatment depends on the size, location, and stage of the cancer.
